Search Results 441-450 of 18521 for Relapse
... relapse must be less than or equal to 12 months); OR have multiple myeloma that is refractory to or has relapsed within 1 year of receiving high-dose ...
... relapse based on the presence of pre-transplant risk factors. Daunorubicin ... relapse in FLT3-ITD mutated AML patients receiving an allogenetic ...
May 4, 2019. Study shows drug reduces risk of relapse with neuromyelitis optica featured image. Featured News. Study shows drug reduces risk of relapse with ...
Latest stories. Mayo researchers correlate specific antibody with relapse of neurological disorder featured image. Featured News. Mayo researchers correlate ...
Study shows drug reduces risk of relapse with neuromyelitis optica featured image. Featured News. Study shows drug reduces risk of relapse with neuromyelitis ...
... relapsed or refractory primary central nervous system lymphoma or newly diagnosed or relapsed or refractory vitreoretinal lymphoma (Intraocular lymphoma).
Mayo researchers correlate specific antibody with relapse of neurological disorder. Gina Chiri-Osmond. November 6, 2018. COPD / sepsis / advances in human ...
This type has a high relapse rate and may spread beyond the skin when it comes back. Intravascular diffuse large B-cell lymphoma. This type is different ...
Mayo Clinic researchers link CAR-T cell aging to cancer relapse featured image. Featured News. Mayo Clinic researchers link CAR-T cell aging to cancer relapse.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.